Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysi

Journal Article · · J. Med. Chem.
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; more »; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; « less

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; FOREIGN; National Institutes of Health (NIH)
OSTI ID:
1810834
Journal Information:
J. Med. Chem., Vol. 64, Issue (14)
Country of Publication:
United States
Language:
ENGLISH

References (83)

Idiopathic pulmonary fibrosis May 2017
Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre May 2019
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy January 2001
Emerging therapeutic interventions for idiopathic pulmonary fibrosis April 2014
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis May 2014
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis May 2014
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases August 2019
Recent advances in the discovery of potent and selective HDAC6 inhibitors January 2018
Inside HDACs with more selective HDAC inhibitors October 2016
Next-generation of selective histone deacetylase inhibitors January 2019
Multiple roles of HDAC inhibition in neurodegenerative conditions November 2009
iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome July 2018
The role of histone deacetylases (HDACs) in human cancer March 2007
Selective histone deacetylase small molecule inhibitors: recent progress and perspectives December 2016
Histone deacetylation in epigenetics: An attractive target for anticancer therapy January 2005
HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis January 2019
Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition July 2008
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme January 2020
Complex networks orchestrate epithelial–mesenchymal transitions February 2006
TGF-β and epithelial-to-mesenchymal transitions August 2005
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis April 2017
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis November 2018
Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis? February 2009
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway October 2017
Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells December 2007
Focal Nature of Neurological Disorders Necessitates Isotype-Selective Histone Deacetylase (HDAC) Inhibitors April 2009
HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases March 2019
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies September 2018
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies September 2016
Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 ( Sm HDAC8) Inhibitors as Multistage Antischistosomal Agents October 2019
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation September 2020
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation February 2021
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition July 2016
HDAC8: a multifaceted target for therapeutic interventions July 2015
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight July 2020
The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins June 2007
BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis March 2019
BAL cell transcriptome predicts survival in IPF and can be used to gauge and model treatment effects interfering with the TGF-beta pathway November 2018
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis January 2018
Mimicking the Intramolecular Hydrogen Bond: Synthesis, Biological Evaluation, and Molecular Modeling of Benzoxazines and Quinazolines as Potential Antimalarial Agents November 2012
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems December 2019
Harmonised high throughput microsomal stability assay March 2017
Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent July 2020
Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors-What Some May Have Forgotten or Would Rather Forget? November 2015
Zebrafish as Toxicological model for screening and recapitulate human diseases February 2018
MC225, a Novel Probe for P-glycoprotein PET Imaging at the Blood–brain Barrier: In Vitro Cardiovascular Safety Evaluation January 2017
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain March 2016
MMFF VI. MMFF94s option for energy minimization studies May 1999
Semiempirical GGA-type density functional constructed with a long-range dispersion correction January 2006
Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: Design and assessment of accuracy January 2005
Accurate Coulomb-fitting basis sets for H to Rn January 2006
The IEF version of the PCM solvation method: an overview of a new method addressed to study molecular solutes at the QM ab initio level May 1999
Generalized Gradient Approximation Made Simple October 1996
Toward reliable density functional methods without adjustable parameters: The PBE0 model April 1999
ECD cotton effect approximated by the Gaussian curve and other methods January 2009
Overview of the CCP 4 suite and current developments March 2011
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM March 2011
How good are my data and what is the resolution? June 2013
Phaser crystallographic software July 2007
Features and development of Coot March 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution January 2010
MolProbity : all-atom structure validation for macromolecular crystallography December 2009
Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates July 2013
Structural characterization of Giardia duodenalis thioredoxin reductase ( g TrxR) and computational analysis of its interaction with NBDHEX July 2017
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages February 2018
Zinc Chelation with Hydroxamate in Histone Deacetylases Modulated by Water Access to the Linker Binding Channel April 2011
Inhibition mechanism of SAHA in HDAC: a revisit January 2015
In silico approaches for investigating the binding propensity of apigenin and luteolin against class I HDAC isoforms August 2018
Docking Ligands into Flexible and Solvated Macromolecules. 6. Development and Application to the Docking of HDACs and other Zinc Metalloenzymes Inhibitors December 2013
Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid: N -Modified SAHA Analogs April 2016
Nonisotopic substrate for assaying both human zinc and NAD+-dependent histone deacetylases August 2003
A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening January 2003
In vitro assays for the determination of histone deacetylase activity August 2005
Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants October 2018
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management March 2011
RNA-Seq quantification of the human small airway epithelium transcriptome January 2012
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18 April 2006
Correction: The K + Channel K Ca 3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis January 2014
DP7, a novel dihydropyridine multidrug resistance reverter, shows only weak inhibitory activity on human CYP3A enzyme(s) July 2009
Evaluation of in vitro cell and blood compatibility and in vivo analgesic activity of plant-derived dietary supplements May 2019
Selective Histone Deacetylase 6 Inhibitors Restore Cone Photoreceptor Vision or Outer Segment Morphology in Zebrafish and Mouse Models of Retinal Blindness August 2020
Negative chronotropism, positive inotropism and lusitropism of 3,5-di-t-butyl-4-hydroxyanisole (DTBHA) on rat heart preparations occur through reduction of RyR2 Ca2+ leak September 2018
Effects of freeze-dried red wine on cardiac function and ECG of the Langendorff-perfused rat heart February 2014

Similar Records

Related Subjects